Arbeitsgruppe Weichteilsarkome - Studien
| Advanced or metastatic soft tissue sarcoma, first and advanced treatment lines | ||||
| AIO-Studie | www.clinicaltrials.gov | zur Studie | ||
| AIO-STS-0415: A randomized phase II study of MEDI4736 and tremelimumab compared to doxorubicin in patients with advanced or metastatic soft tissue sarcoma. MEDISARC | ||||
| ---in Rekrutierung--- | ||||
| Gastrointestinal stromal tumor (GIST) | ||||
| AIO-assoziierte Studie | www.clinicaltrials.gov | zur Studie | ||
| AIO-STS-0115/ass: Phase 2 trial of ponatinib in patients with metastatic and/or unresectable gastrointestinal stromal tumor (GIST) following failure of prior therapy with imatinib (POETIG trial – POnatinib after rEsisTance to Imatinib in GIST) | ||||
| ---in Rekrutierung --- | ||||
| Gastrointestinal stromal tumor (GIST), adjuvante Therapie |
||||
| AIO-assoziierte Studie | www.clinicaltrials.gov | zur Studie | ||
| AIO-STS-0317/ass: Three versus five years of adjuvant imatinib as treatment of patients with operable GIST with a high risk for recurrence: A randomised phase III study |
||||
| ---in Rekrutierung --- | ||||
| Chordome, Knochensarkome, fortgeschrittene Erkrankung | ||||
| AIO-assoziierte Studie | Für weitere Zentren offen | www.clinicaltrials.gov | zur Studie | |
| AIO-STS-0217/ass: CDK4/6 inhibition in locally advanced/metastatic chordoma - NCT-PMO-1601 | ||||
| ---in Rekrutierung --- | ||||
| Solide Tumore mit DNA-Reparatur Defizienz, fortgeschrittene Erkrankung | ||||
| AIO-assoziierte Studie | Für weitere Zentren offen | www.clinicaltrials.gov | zur Studie | |
| AIO-STS/TF-0117/ass: Randomized Phase-2 Study of Trabectedin/Olaparib Compared to Physician’s Choice in Subjects with Previously Treated Advanced or Recurrent Solid Tumors Harboring DNA Repair Deficiencies - NCT-PMO-1603 |
||||
| ---in Rekrutierung--- | ||||
| LETZTE AKTUALISIERUNG DIESER SEITE AM: 25.04.2019 |